DLG4 and dementia: Among the predicted DTs, numerous serine threonine kinases, such as DLG4 (PSD-95) and a G-protein coupled receptor, Bradykinin receptors 2, were highlighted which could be considered for the development of innovative therapeutic approaches for the treatment of dementia.